MENU
+Compare
ADTX
Stock ticker: NASDAQ
AS OF
Apr 24, 01:34 PM (EDT)
Price
$2.29
Change
-$0.02 (-0.87%)
Capitalization
2.79M

ADTX Aditxt Inc Forecast, Technical & Fundamental Analysis

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system... Show more

ADTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ADTX with price predictions
Apr 23, 2025

ADTX's RSI Oscillator stays in oversold zone for 10 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where ADTX advanced for three days, in of 181 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 01, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ADTX as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ADTX entered a downward trend on April 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.618) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (2.236) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ADTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ADTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ADTX is expected to report earnings to rise 4,058.27% to -11559 cents per share on August 30

Aditxt Inc ADTX Stock Earnings Reports
Q2'23
Est.
$-115.60
Q1'23
Est.
$-2.78
Q4'22
Missed
by $0.48
Q3'22
Missed
by $1.38
Q2'22
Missed
by $253.50
The last earnings report on May 31 showed earnings per share of -277 cents, meeting the estimate of -277 cents. With 46.94K shares outstanding, the current market capitalization sits at 2.79M.
A.I. Advisor
published General Information

General Information

a life sciences company which engages in the development of nucleic acid (DNA)-based technologies to minimize rejection of transplanted organs by human recipients as well as address autoimmune diseases and allergies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
737 North Fifth Street
Phone
+1 650 870-1200
Employees
61
Web
https://www.aditxt.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH209.571.19
+0.57%
Clean Harbors
CDNA17.830.05
+0.31%
CareDx
TIXT2.47-0.01
-0.40%
TELUS International (Cda)
YTRA0.67-0.06
-8.68%
Yatra Online
KWE0.22-4.40
-95.24%
Kwesst Micro Systems Inc

ADTX and Stocks

Correlation & Price change

A.I.dvisor tells us that ADTX and ORMP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADTX and ORMP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADTX
1D Price
Change %
ADTX100%
N/A
ORMP - ADTX
32%
Poorly correlated
+0.66%
CSCI - ADTX
28%
Poorly correlated
+2.47%
XTLB - ADTX
27%
Poorly correlated
-7.25%
BDRX - ADTX
25%
Poorly correlated
+1.43%
APRE - ADTX
25%
Poorly correlated
-1.62%
More